74 results
Page 2 of 4
6-K
EX-99.2
dx28qg1
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
bd5trvl8ghkrrfb6f
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.2
sk3es 6x5ch
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
ss1dv 7dfn3m
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.2
xobo414
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
rj66 krnfyac8mfqo0
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
rech6es
22 Jan 19
Current report (foreign)
4:43pm
6-K
EX-99.2
rw3meh8becftjd
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.2
whog3u0jzjsfspd
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
20-F/A
o7yq wd1os9
12 Jan 18
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
ipdzext1xinbxvhxtf
20 Apr 16
RepliCel Life Sciences Finishes Enrolment for its Tendon Repair and Skin Rejuvenation Clinical Trials
12:00am
6-K
EX-99.2
oukinab atswbapc
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
7fec ukdz
9 Sep 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.2
9odcw720qsmm
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
s80ic9f44928h
18 Jun 14
RepliCel Life Sciences Announces Closing of Third and Final Tranche of
12:00am